These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2869617)

  • 21. Risk stratification for malignant arrhythmic events in patients with an acute myocardial infarction: role of an open infarct-related artery and the signal-averaged ECG.
    Hermosillo AG; Araya V; Casanova JM
    Coron Artery Dis; 1995 Dec; 6(12):973-83. PubMed ID: 8723020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blockers in chronic treatment after acute myocardial infarction.
    Fogari R; Zoppi A
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S68-71. PubMed ID: 2483236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can exercise testing in patients with a history of myocardial infarction predict fatal and non-fatal reinfarction?
    Casella G; Pavesi PC; di Niro M; Medda M; Camplese MG; Bracchetti D
    G Ital Cardiol; 1998 Jan; 28(1):12-21. PubMed ID: 9493041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of a patient recovering from myocardial infarction: a decision tree.
    Bush DE; Healy B
    Adv Intern Med; 1986; 31():469-93. PubMed ID: 2868622
    [No Abstract]   [Full Text] [Related]  

  • 26. [Life-threatening complications of ergometry].
    Mildenberger VD; Kaltenbach M
    Fortschr Med; 1989 Sep; 107(27):569-71. PubMed ID: 2680838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The use of labetalol and propranolol in patients who have had a myocardial infarct].
    Il'iash MG; Kravtsova LA; Babov KD; Shcherbak IaIu
    Vrach Delo; 1990 May; (5):26-8. PubMed ID: 2396387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does beta adrenergic blockade influence the prognostic implications of post-myocardial infarction exercise testing?
    Murray DP; Tan LB; Salih M; Weissberg P; Murray RG; Littler WA
    Br Heart J; 1988 Dec; 60(6):474-9. PubMed ID: 2906251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of patients who do not require beta antagonists after myocardial infarction.
    Ahumada GG
    Am J Med; 1984 May; 76(5):900-4. PubMed ID: 6144270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical appraisal of secondary prevention after myocardial infarction. What have beta-blockers to offer in the experimental situation?
    Parratt JR
    Eur Heart J; 1986 Jul; 7 Suppl B():19-25. PubMed ID: 2875873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations of the scientific councils of the International Society and Federation of Cardiology on risk reduction after myocardial infarction.
    Koenig K
    Adv Cardiol; 1986; 33():28-39. PubMed ID: 2882652
    [No Abstract]   [Full Text] [Related]  

  • 32. Beta-adrenoceptor blocking drugs in primary and secondary prevention of myocardial infarction.
    Dollery CT
    Eur Heart J; 1987 Dec; 8 Suppl M():131-4. PubMed ID: 2897296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which patients for secondary prevention with beta-blocking drugs?
    Chamberlain D; Campbell S
    Eur Heart J; 1986 Jul; 7 Suppl B():53-8. PubMed ID: 2875876
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of propranolol in postinfarction patients with mechanical or electrical complications.
    Furberg CD; Hawkins CM; Lichstein E
    Circulation; 1984 Apr; 69(4):761-5. PubMed ID: 6365352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-adrenergic blockers.
    Frishman WH
    Med Clin North Am; 1988 Jan; 72(1):37-81. PubMed ID: 2892986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Submaximal exercise testing early after myocardial infarction.
    Wilkes N; Watkins J
    Br Heart J; 1985 Feb; 53(2):236. PubMed ID: 2857089
    [No Abstract]   [Full Text] [Related]  

  • 37. The high-risk surgical patient and the role of preoperative management.
    Girbes AR
    Neth J Med; 2000 Sep; 57(3):98-105. PubMed ID: 10978555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blocker therapy after myocardial infarction: secondary prevention in all patients?
    Griggs T; Adams K; Narvarte H; Sheps D
    Z Kardiol; 1985; 74 Suppl 6():173-8. PubMed ID: 2869617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Electric stability of the heart after myocardial infarction: role of anti-arrhythmia agents during postinfarction].
    Sadoul N; Aliot E
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):773-80. PubMed ID: 1356328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-blocker underuse in secondary prevention of myocardial infarction.
    Everly MJ; Heaton PC; Cluxton RJ
    Ann Pharmacother; 2004 Feb; 38(2):286-93. PubMed ID: 14742768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.